Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients

Table 2 Baseline characteristics

	HIV (%)	Hepatitis monoinfection (%)	p-value
Men	55 (57)	41(57)	0.96
Women	41 (43)	31 (43)	0.96
Total	96	72
Age	43 ± 9	43 ± 12	0.75
Opiat consumption/ substitution	31 (32)	23 (32)	0.82
Diabetes mellitus	5 (5)	2 (3)	0.65
HCV infection	36 (37)	50 (69)	<0.001

ISSN: 1471-2334